Sign in
Enrolling by invitationNo phase

Testing ways to help primary care clinics diagnose familial hypercholesterolemia

Tests strategies to improve familial hypercholesterolemia diagnosis in primary care clinics, for adults.

Key facts

Who runs it
Geisinger Clinic
Where
Multiple Locations, United StatesSee the site
Trial code
Registry title
Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
Status
Enrolling by invitation
People taking part
532 people, planned
Started
9 Sept 2022
Expected to end
Jan 2027
Type of study
Interventional, 5 groups
Treatments tested
  • FH diagnosis program
  • Implementation strategy package: Develop and implement tools for quality monitoring
  • Implementation strategy package: Develop educational materials
  • Implementation strategy package: Conduct educational outreach visits
  • Implementation strategy package: Intervene with clinicians and patients to enhance
  • Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions
  • Implementation strategy package: Audit and provide feedback
  • Implementation strategy package: Stage implementation scale up
Record updated
22 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for primary care clinicians (pediatrics, community medicine, internal medicine) in the Geisinger Healthcare System. It tests ways to improve diagnosis of familial hypercholesterolemia.

Age
26 Years and older
Sex
All

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Primary care clinicians (pediatrician, community medicine, internal medicine) in the Geisinger Healthcare System

Who cannot take part

  • None

Where in United States

  • Geisinger ClinicMultiple Locations, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Diagnosis rates of familial hypercholesterolemia (FH) are low in the United States, despite multiple guidelines and recommendations for screening and treatment of high cholesterol, to prevent heart attacks in those affected. Using a stepped-wedge design, the investigators plan to utilize tools from implementation science to improve uptake, acceptability, and sustainability of FH diagnostic programs in primary care settings. If successful, this study will provide tools generalizable to other health care systems to improve FH diagnosis rates.

The 5 groups in the trial

  • Phase 1Other group

    Phased rollout to clinic sites across the the Geisinger system using stepped wedge design

    Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up

  • Phase 2Other group

    Phased rollout to clinic sites across the the Geisinger system using stepped wedge design

    Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up

  • Phase 3Other group

    Phased rollout to clinic sites across the the Geisinger system using stepped wedge design

    Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up

  • Phase 4Other group

    Phased rollout to clinic sites across the the Geisinger system using stepped wedge design

    Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up

  • Phase 5Other group

    Phased rollout to clinic sites across the the Geisinger system using stepped wedge design

    Treatment: FH diagnosis program, Implementation strategy package: Develop and implement tools for quality monitoring, Implementation strategy package: Develop educational materials, Implementation strategy package: Conduct educational outreach visits, Implementation strategy package: Intervene with clinicians and patients to enhance, Behavioral (e.g., Psychotherapy, Lifestyle Counseling) Implementation strategy package: Identify and prepare champions Clinical lipid champions, Implementation strategy package: Audit and provide feedback, and Implementation strategy package: Stage implementation scale up

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
Plain-language title
Testing ways to help primary care clinics diagnose familial hypercholesterolemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
22 December 2025